Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells

BMC Pharmacol Toxicol. 2023 Oct 27;24(1):57. doi: 10.1186/s40360-023-00688-5.

Jui-Ting Chang^{1

2}, Yao-Jen Liang^{3

4}, Chia-Yu Hsu³, Chao-Yi Chen⁴, Po-Jung Chen⁴, Yi-Feng Yang⁴, Yen-Lin Chen^{5

6}, Dee Pei^{7

6}, Jin-Biou Chang⁸, Jyh-Gang Leu^{9

10}

¹ Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
² Department & Institute of Pharmacology, National Yang Ming University, Taipei, Taiwan.
³ Department and Institute of Life Science, Fu-Jen Catholic University, New Taipei, Taiwan.
⁴ Graduate Institute of Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan.
⁵ Department of Pathology, Cardinal Tien Hospital, Medical School, Fu Jen Catholic University, New Taipei City, Taiwan.
⁶ Fu-Jen Catholic University School of Medicine, No. 510, Zhongzheng Road, Xinzhuang District, 24205, New Taipei City, Taiwan.
⁷ Division of Endocrinology and Metabolism, Department of Internal Medicine, Cardinal Tien Hospital, Medical School, Fu Jen Catholic University, New Taipei City, Taiwan.
⁸ Department of Pathology, Division of Clinical Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan.
⁹ Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. 056111@mail.fju.edu.tw.
¹⁰ Fu-Jen Catholic University School of Medicine, No. 510, Zhongzheng Road, Xinzhuang District, 24205, New Taipei City, Taiwan. 056111@mail.fju.edu.tw.

No abstract available

Publication types